COMPRAR AHORA
¿HIPERPLASIA DE PRÓSTATA, CONTROL del PSA?
EPILOBIUM BIOVER: la respuesta más saludable
Promoción Epilobio: Para el Tratamiento de 2 Meses, el precio de la unidad es de 7,37 en lugar de 10,50.
Si su especialista le ha recetado EPILOBIO (EPILOBIUM PARVIFLORUM), la presentación de los laboratorios belgas BIOVER es en gotas (la más efectiva) y formulada con ingredientes de alta calidad (Epilobio ecológico con certificado Bio).
(VER ABAJO ARTÍCULO DE LA UNIVERSIDAD DE QUEENSLAND (SCHOOL OF MEDECINE) SOBRE LA EFECTIVIDAD DEL EPILOBIO SOBRE LA HIPERPLASIA DE PRÓSTATA)*
Epilobium Parviflora de Biover es un extracto fitoterapéutico de influencia clínicamente probada sobre el estado de las vías urinarias y de la próstata. En especial se ha constatado con su uso diario el descenso del PSA y la reducción del tamaño de la próstata en lahiperplasia prostática benigna (Ver abajo artículo de la School of Medicine de la Universidad de Queensland)*
Además, es ampliamente recetado para frenar la alopecia androgénica (caída de cabello masculina) e igualmente se le atribuyen propiedades depurativas, astringentes (cicatrizantes y antiinflamatorias) se usa igualmente para combatir gastrointeritis y otras inflamaciones de la mucosa digestiva. El Epilobio de Biover procede del cultivo ecológico. Se presenta en Gotas (la presentación más adecuada para este tipo de planta), y se toma 1ml tres veces al día con agua, zumo o sólo. (25 a 30 gotas por toma). *Artículo que expone el estudio clínico realizado con Epilobio y su beneficioso efecto sobre la hiperplasia de próstata.
Autores: Coulson S1, Rao A, Beck SL, Steels E, Gramotnev H, Vitetta L.
University of Queensland, School of Medicine,Centre for Integrative Clinical and Molecular Medicine, Brisbane, QLD 4102, Australia.
Abstract
A phase II randomised double-blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy.
Abstract
OBJECTIVE:
The aim of the clinical trial was to evaluate the efficacy and safety of ProstateEZE Max, an orally dosed herbal preparation containing Cucurbita pepo, Epilobium parviflorum, lycopene, Pygeum africanum and Serenoa repens in the management of symptoms of medically diagnosed benign prostate hypertrophy (BPH).
DESIGN:
This was a short-term phase II randomized double-blind placebo controlled clinical trial.
SETTING:
The trial was conducted on 57 otherwise healthy males aged 40-80 years that presented with medically diagnosed BPH.
INTERVENTION:
The trial participants were assigned to receive 3 months of treatment (1 capsule per day) with either the herbal preparation (n = 32) or a matched placebo capsule (n = 25).
OUTCOME MEASURES:
The primary outcome measure was the international prostate specific score (IPSS) measured at baseline, 1, 2 and 3 months. The secondary outcomes were the specific questions of the IPSS and day-time and night-time urinary frequency.
RESULTS:
There was a significant reduction in IPSS total median score in the active group of 36% as compared to 8% for the placebo group, during the 3-months intervention (p < 0.05). The day-time urinary frequency in the active group also showed a significant reduction over the 3-months intervention (7.0-5.9 times per day, a reduction of 15.6% compared to no significant reduction change for the placebo group (6.2-6.3 times per day) (p < 0.03). The night-time urinary frequency was also significantly reduced in the active group (2.9-1.8, 39.3% compared to placebo (2.8-2.6 times, 7%) (p < 0.004).
CONCLUSION:
The herbal preparation (ProstateEZE Max) was shown to be well tolerated and have a significant positive effect on physical symptoms of BPH when taken over 3 months, a clinically significant outcome in otherwise healthy men. Copyright © 2013 Elsevier Ltd. All rights reserved.
- PMID:
- 23642948
- [PubMed – indexed for MEDLINE]